The Latest Cardiac and Vascular News
The study met secondary study endpoints and long-term sensor use was associated with significant improvements in patient quality-of-life metrics and low event rates for heart failure hospitalization and death LISLE, Ill., May 22, 2023 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), […]
“Gold Standard” SphygmoCor® Technology to be Used to Identify Care Outcomes Associated with Routine Monitoring of Patients with Elevated Blood Pressure IRVINE, Calif., May 22, 2023 /PRNewswire/ — ATCOR Medical, a subsidiary of CardieX and developer of innovative medical devices and digital health solutions to optimize hypertension management and improve clinical trial patient outcomes, today announced […]
Data Presented at Late-Breaking Session at Heart Rhythm Society 2023: Paves Way for Premarket Approval Application for Federal Drug Administration Approval and Commercialisation The pivotal SOLVE-CRT study evaluated EBR Systems’ WiSE® CRT System, the world’s first and only wireless, inside the left ventricle of the heart, pacing system for heart […]
A team of six leading European interventional radiologists used the LIBERTY® Surgical Robotic System and performed a total of 48 catheterizations HINGHAM, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Surgical Robotic System, the first single-use endovascular robotic system, today announced a […]
IRVINE, Calif., May 22, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced planned enrollment of the PEERLESS II trial, Inari’s third randomized controlled trial (RCT) in […]
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular disorders with high unmet medical need, today announced that it presented additional biomarker data […]
Oak Ridge, TN, May 22, 2023 (GLOBE NEWSWIRE) — DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the pricing of its previously announced underwritten public offering of 410,260 shares of its common stock at a public offering price of $9.75 […]
– Study Led by John Mignone, M.D., Ph.D., Presented at the Heart Rhythm Society’s Annual Meeting – – Key Findings Demonstrate Increased Survival for Patients Receiving Combined Device and 4-Class Medical Therapy – ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, Inc., a leading digital health company for cardiovascular care, announces today the release of novel […]
IDENTIFY PH presented at ATS WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis, announces the presentation of a machine-learned algorithm to IDENTIFY PH at the American Thoracic Society (ATS) conference. This proof of concept showcases the effectiveness of a machine learned (ML) phase […]
IRVINE, Calif., May 18, 2023 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced the completion of the first two Trilogy Heart Valve System implantations in Asia. The two procedures were performed by Dr. Michael Lee and team at Queen […]
